Harvard Apparatus Regenerative Technology Inc.
HRGN
$2.18
-$0.17-7.40%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 982.00K | 885.00K | 704.00K | 743.00K | 679.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 982.00K | 885.00K | 704.00K | 743.00K | 679.00K |
| Cost of Revenue | 908.00K | 819.00K | 646.00K | 622.00K | 580.00K |
| Gross Profit | 74.00K | 66.00K | 58.00K | 121.00K | 99.00K |
| SG&A Expenses | 3.97M | 4.36M | 4.37M | 4.54M | 4.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.69M | 7.74M | 7.62M | 7.33M | 7.41M |
| Operating Income | -6.71M | -6.85M | -6.92M | -6.58M | -6.73M |
| Income Before Tax | -6.68M | -6.81M | -6.87M | -6.53M | -6.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.68 | -6.81 | -6.87 | -6.53 | -6.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.68M | -6.81M | -6.87M | -6.53M | -6.69M |
| EBIT | -6.71M | -6.85M | -6.92M | -6.58M | -6.73M |
| EBITDA | -6.71M | -6.85M | -6.91M | -6.58M | -6.72M |
| EPS Basic | -0.39 | -0.40 | -0.42 | -0.40 | -0.43 |
| Normalized Basic EPS | -0.24 | -0.25 | -0.26 | -0.25 | -0.27 |
| EPS Diluted | -0.39 | -0.40 | -0.42 | -0.40 | -0.43 |
| Normalized Diluted EPS | -0.24 | -0.25 | -0.26 | -0.25 | -0.27 |
| Average Basic Shares Outstanding | 69.38M | 67.72M | 66.06M | 64.80M | 62.78M |
| Average Diluted Shares Outstanding | 69.38M | 67.72M | 66.06M | 64.80M | 62.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |